New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 12, 2017 – Amneal Biosciences announced the FDA approval of an AP-rated generic version of Bristol-Myers Squibb’s Kenalog- 40 (triamcinolone acetonide) injection.
Download PDF
Return to publications
